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INTRODUCTION
Neutrophils are thought to play a central role in
combating bacterial infection in the lower respiratory tract
(1,2). They are also thought to be involved in the
pathogenesis of various pulmonary diseases, such as
pulmonary emphysema, idiopathic pulmonary fibrosis
(IPF) and cystic fibrosis(3-5). Neutrophils are rare in the
alveolar space or respiratory tract of normal persons(6).
Therefore, neutrophils are thought to be attracted to
disease lesions from the peripheral circulation by various
neutrophil chemotactic factors(NCFs). NCFs have been
characterized in the respiratory tract and are thought to
be responsible for neutrophil infiltration in pulmonary
diseases. Different NCFs, such as cell-derived NCF(7-12),
complement derived NCF(13), and bacterium-derived
NCF(14)may correspond to various pathophysiologic
states of the lung. We have already reported that different
types of NCFs exist in bronchoalveolar lavage fluid
(BALF) obtained from patients with chronic airway
diseases and IPF, suggesting that the main NCF, which
neutrophils accumulate in the lung, may differ with each
disease(15).
IL-8, previously referred to as monocyte-derived neutro-
phil chemotactic factor or neutrophil activating peptide-1,
is a 72 amino acid polypeptide that has potent neutrophil
activating and chemotactic activities(9,16,17). IL-8 has
been demonstrated in a number of inflammatory disease
states, including rheumatoid arthritis(18), sepsis(19)and
adult respiratory distress syndrome(20). IPF is character-
ized by the accumulation of neutrophils and mononuclear
cells, followed by the progressive deposition of collagen
within the interstitium and subsequent destruction of lung
air spaces(4). Although the mechanism of cellular injury
is unclear, neutrophils are thought to play important roles.
Diffuse panbronchiolitis(DPB), a lung disease in which
chronic inflammation is restricted to the respiratory
bronchioles, is common in Japan(21). As the disease
progresses, the inflammatory changes extend to the
proximal airways and inflammation due to bacterial
infection is superimposed(22), and it is thought that
neutrophil accumulation is responsible for tissue damage.
Thus, in IPF and DPB, neutrophils which accumulate in
the disease site are thought to play important roles in the
pathogenesis of the disease. On the other hand, various
types of NCF may cause the accumulation of neutrophils
in these diseases. In this study, to examine whether IL-8
was responsible for accumulation of neutrophils in the
lower respiratory tract, we measured IL-8 concentration in
BALF and examined the correlation between IL-8 concen-
tration and neutrophil chemotactic activity in BALF
obtained from patients with IPF or DPB.
MATERIALS AND METHODS
Subjects
Four groups of subjects were studied : patients with
DPB, patients with IPF, normal volunteers, and control
patients.
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The DPB group consisted of ten patients with DPB(6
males and 4 females). Patients with DPB were diagnosed
clinically on the basis of the clinical, functional and
radiological criteria proposed by the Committee for
Diffuse Panbronchiolits (part of the Interstitial Pulmonary
Research Project of the Ministry of Public Welfare of
Japan)(21,22). All demonstrated an increased volume of
sputum. The presence of bacteria in the sputa of patients
was examined at the time BAL was performed and 2
Hemophilus influenzae,1 Streptococcus peumoniae, and 2
Pseudomonas aeruginosa were detected. The results of
the others showed normal flora. These patients were not
treated with erythromycin at that time. The average age of
the ten patients was 46±14 yrs(all data are presented as
mean±SD). Four patients were former smokers and six
non-smokers.
The IPF groups consisted of 11 patients. The diagnosis
of IPF was based on clinical symptoms, chest roent-
genograms, pulmonary function tests, and histologic
findings that showed interstitial fibrosis compatible with
IPF in more than two specimens obtained by repeated
transbronchial biopsy from different parts of the lung. No
patient had evidence of sarcoidosis, hypersensitivity
pneumonitis, collagen-vascular diseases, or a history of
significant occupational exposure or glucocorticoid treat-
ment. The average age of this group was 57±13 yrs and
all were men. Five did not smoke and the others were
former smokers.
The normal volunteer(NV)group consisted of 7 healthy
volunteers who were without symptoms and had no
abnormal findings on chest roentgenogram or pulmonary
function testing. Their average age was 22±1 yr ; all were
men, 4 were non-smokers, 3 were smokers of less than 3
pack years.
The control patients(CP)group consisted of 9 patients
who had a localized lung lesion such as lung cancer. No
patient received any treatment. Their average age was 56
±13 yrs ; all were men, 2 were non-smokers, 3 were ex-
smokers and 4 were current smokers. BAL was per-
formed on the non-affected lung, and the BALF obtained
was used as an age-matched control for the patients with
DPB and IPF.
Informed consent was obtained from every NV and
patient.
Bronchoalveolar Lavage
As described previously(23), BAL was performed with a
flexible bronchofiberscope in the subsegmental bronchus,
B4 or B5 of the right lung of NV, for the DPB and IPF
groups, and non-affected lungs of CP. Fifty milliliters of
sterilized saline was introduced gently by syringe through
the bronchoscope and recovered after one deep inspira-
tion. This procedure was repeated three times and the
BAL fluids were pooled, filtered through three layers of
gauze and centrifuged at 200 Xg for 10 min to separate the
cells from the fluid. The fluid was stored at -70℃ for the
assays of neutrophil chemotactic activity and IL-8 concen-
tration. The cells were washed twice with phosphate
buffered saline (PBS) and counted in a hemocytometer.
Differential cell counts were performed using May-
Giemsa and non-specific esterase staining.
Measurement of Neutrophil Chemotactic Activity
Neutrophil chemotactic activity (NCA) in the BALF was
measured using the membrane filter method and a 48-well
microchemotactic chamber (Neuro Probe, Inc., Bethesda,
MD) as described by Falk and coworkers(24). Neutro-
phils were purified from the peripheral blood of a normal
volunteer by the sedimentation method of Böyum(25)and
suspended at a concentration of 3 X 106 per ml in PBS
containing 0.4% bovine serum albumin (BSA) (Sigma). A
30 μl aliquot was placed into the lower well separated by a
membrane filter with 3 μm diameter pores, and the upper
well was filled with 50 μl of neutrophil suspension. The
chamber was kept standing for 30 min at 37℃ under 5%
CO2 in air. Then, the filter was removed and stained with
Diff-Quik (Harleco, Gibbstown, NJ). The cells that mi-
grated through the filter to the other side were counted in
five microscopic fields and NCA was expressed as the
average cell number per high power field(1 X 1000). In
each experiment, a negative control was assessed using
saline. A positive control was assessed using 10-6-10-9M N-
formyl-Met-Leu-Phe (fMLP ; Sigma).
Measurement of IL-8 in BALF
The IL-8 concentration in BALF was measured using an
ELISA kit (Research and Diagnostic System, Minneapolis,
MN). A standard curve was sufficient to measure
concentrations of IL-8 from 4.7 pg/ml to 1200 pg/ml. The
IL-8 concentration was expressed as pg/ml in BALF.
Statistical Analysis
Results are expressed as the mean±SD. The signifi-
cance of differences between values was evaluated by
Student's t-test. Correlation was examined by Spearman's
correlation coefficients method. p values of 0.05 or less
were considered to be significant.
RESULTS
Cell Numbers in BALF
The total cell and neutrophil counts in BALF obtained
from the control groups and patients with IPF and DPB
are shown in Table 1. The mean total cell count in BALF
from patients with DPB and IPF was higher (p<0.05) than
in NV. The neutrophil counts in BALF from patients with
DPB and IPF were also higher (p<0.05) than in NV and
CP. The mean neutrophil count in BALF from CP was
slightly, but not significantly, higher than that in BALF
from NV. The neutrophil count in patients with DPB was
higher than that from patients with IPF (p<0.05).
Neutrophil Chemotactic Activity in BALF
NCA in BALF obtained from control groups and
patients with DPB and IPF are shown in Table 2. NCA in
BALF obtained from patients with DPB and IPF was
significantly higher than that from CP or NV (p<0.05).
NCA in BALF from CP was also higher than that from NV
(p<0.05). NCA in the BALF from patients with DPB was
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higher than that in BALF from patients with IPF (p<0.05).
Concentration of IL-8 in BALF
The concentrations of IL-8 in BALF from normal
individuals and patients with DPB and IPF are shown in
Fig 1. The concentration of IL-8 in BALF from NV and CP
was 37±17 pg/ml and 53±18 pg/ml, respectively (not
significantly different). The concentrations of IL-8 in BALF
from patients with DPB and IPF were 357±301 pg/ml
and 102±35 pg/ml, respectively. In both patient groups,
the level was significantly higher than in control groups (p
<0.05). Further, the IL-8 concentration from patients with
DPB was higher (p<0.05)than that from patients with IPF.
Correlation between the IL-8 concentration and neutrophil
count or NCA in BALF
There was no correlation between the IL-8 concentra-
tion and neutrophil count in BALF obtained from patients
with DPB (Fig.2 A). On the other hand, a significant
correlation (p<0.01) was found between the IL-8 concen-
tration and neutrophil count in BALF from patients with
IPF (Fig 2 B). There was no correlation between the IL-8
concentration and NCA in BALF obtained from patients
with DPB (Fig 3 A). However, a significant correlation (p<
0.01)was found between the IL-8 concentration and NCA
in BALF obtained from patients with IPF(Fig.3 B).
Fig. 1. Concentration of IL-8 in BALF obtained from normal
individuals and patients with IPF or DPB. The results are
expressed as pg/ml of IL-8 in BALF. Definition of abbreviations,
NV : normal volunteer, CP : control patients. For other definitions,
see Table 1.
Fig. 2. Correlation between concentrations of IL-8 and neutrophil
counts in BALF obtained from patients with DPB (A) or IPF (B).
The results are expressed as pg/ml of IL-8 in BALF and the
neutrophil count per ml of BALF. For a definition of abbreviations,
see Table 1.
Table 1. Neutrophil Count in Bronchoalveolar Lavage Fluid*







Patients with DPB 10









Definition of abbreviations : BALF=bronchoalveolar lavage fluid,
DPB=diffuse panbronchiolits, IPF=idiopathic pulmonary fibrosis
*Values are expressed as the mean±SD
†P<0.05 compared to normal volunteers
‡P<0.05 compared to normal volunteers and control patients
¶P<0.05 compared to patients with IPF
Table 2. Neutrophil Chemotactic Activity in Bronchoalveolar
Lavage Fluid*
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Definition of abbreviations : hpf=high power fluid
For other definitions, see Table 1.
*Values are expressed as the mean±SD
†P<0.05 compared to normal volunteers and control patients
‡P<0.05 compared to patients with IPF
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DISCUSSION
Neutrophils that accumulate in the lower respiratory
tract are thought to be involved in the pathogenesis of
various pulmonary diseases. Neutrophil accumulation is
caused by various NCFs, which are derived from bacteria
(14), serum(26), complement(13)and cells(7-12). Various
NCFs have been detected in BALF from patients with
pneumonia(27), adult respiratory distress syndrome(28),
IPF(15, 29)and cystic fibrosis(5).
Recently, IL-8, which is a polypeptide with specific
neutrophil chemotactic activity, has been cloned. IL-8 is
produced by monocytes/macrophages (9, 16, 30), fibro-
blasts(10, 31), epithelial cells(11, 32)and mast cells(12)in
response to an exogenous or endogenous signal. IPF and
DPB are chronic inflammatory diseases which are
characterized by the accumulation of neutrophils in the
lower respiratory tract(15, 29, 33). However, the disease
site in DPB differs from that in IPF. In patients with DPB,
the airways, particularly the peripheral airways and
intermediate zones are thought to be narrowed by
inflammation of the bronchiolar walls(21,22). In IPF, the
disorders are invariably associated with inflammation of
interstitium(4).
In the present study, we examined whether the
contribution of IL-8 to neutrophil accumulation into the
disease site may differ between DPB and IPF. To test this
hypothesis, we measured the IL-8 concentration in the
BALF of patients with IPF and DPB, and compared these
IL-8 concentrations to the NCA levels in the BALF of
these patients. NCA in BALF from patients with DPB and
IPF was higher than that from NV or CP. There is no
correlation between the IL-8 concentration and NCA in
the BALF of patients with DPB. We have noticed that
BALF from patients with chronic airway disease contained
different types of NCF such as coplement, IL-8 and LTB4
(15). Therefore, the discrepancy between IL-8 concentra-
tion and NCA in BALF from DPB patients may be
explained as follows. That is, chief NCFs, which contrib-
ute to the accumulation of neutrophils in the lower
respiratory tract may differ with the disease state of DPB.
Furthermore, NCF may be inactivated by various
inhibitors in BALF from DPB patients(34, 35). On the
other hand, there is a correlation between the IL-8
concentration and BALF NCA in patients with IPF. These
results suggested that IL-8 is an important NCF in the
lower respiratory tract of the IPF lung. IL-8 in the BALF of
IPF patients is thought to be produced by various lung
cells, such as alveolar macrophages, endothelial cells, and
fibroblasts. The alveolar macrophages seem to be of
primary importance among lung cells. Increased numbers
of activated alveolar macrophages have been found by
BAL and within the alveolar space and wall in IPF(36, 37).
Lynch et al. have reported that BAL cells from patients
with IPF constitutively express mRNA for IL-8,however,
BAL cells from healthy subjects failed to express
constitutively mRNA of IL-8(38). Carre et al. showed using
reverse transcription polymerase chain reaction that
expression of the IL-8 gene by alveolar macrophages is
increased in IPF and the level of IL-8 mRNA correlated
with the number of neutrophils per mililiter in the BALF.
They also demonstrated that the IL-8 level in BALF
reflected the pattern of IL-8 mRNA expression by alveolar
macrophages(39). Thus, alveolar macrophages appear to
be the major cellular source of the IL-8 in BALF obtained
from patients with IPF. Therefore, IL-8 derived from
alveolar macrophages is thought to be an important NCF
in the lower respiratory tract of the IPF lung and may
contribute to the involvement of neutrophils in the
pathogenesis of IPF. Moreover, Nakamura et al.
demonstrated that alveolar macrophages of patients with
IPF were primed for IL-8 production(40).
In the present study, we demonstrated that the IL-8
level was elevated in the BALF of patients with DPB or
IPF when compared with the control. There was a
correlation between IL-8 concentration and NCA in BALF
from patients with IPF, but not DPB. These results
suggest that the NCF increases specifically according to
the particular pathophysiologic state and that NCF is
produced in response to a specific pathogen or disease
state.
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